GE, Abbott back out of diagnostics deal
This article was originally published in Clinica
Executive Summary
Less than six months after inking the deal, GE and Abbott are now scrapping the proposed $8.13bn sale of Abbott's point-of-care and lab diagnostics businesses to GE. The companies said they had reached a mutual decision to call off the deal as they could not agree on the final terms and conditions.